Study zeroes in on efficacy of cardiac devices in women

06/30/2014 |

Female heart failure patients who received cardiac resynchronization devices faced a 60% lower risk of mortality or complications related to the condition, while risk reduction was 26% in men. However, women make up less than 30% of the estimated 100,000 patients who receive the devices each year. Medical device studies tend to include relatively few women, and the dearth of efficacy information may explain why fewer women are treated with the devices.

View Full Article in: